MALIA LEWIS: Open Payments
NPI 1053033316 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,204 in 11 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $235 · 2025 $1,204
Food & beverage: $1,204
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $364 |
| Otsuka America Pharmaceutical, Inc. | 2 | $238 |
| Alkermes, Inc. | 2 | $229 |
| Janssen Pharmaceuticals, Inc | 2 | $137 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
| E.R. Squibb & Sons, L.L.C. | 1 | $113 |
Products named: CAPLYTA, ABILIFY MAINTENA, INVEGA SUSTENNA, INGREZZA, ARISTADA, COBENFY, LYBALVI.
Industry payments across CO — which companies pay providers there.
